Riku Heikki Rautsola
Keine laufenden Positionen mehr
Profil
Riku Heikki Rautsola served as President & Chief Executive Officer at VIRxSYS Corp., Chief Executive Officer at Borean Pharma ApS, Chief Executive Officer at Cosmix molecular biologicals GmbH, and President & Chief Executive Officer at Corden Pharma SpA.
He also held the position of President & Chief Executive Officer at Laurantis Pharma Oy from 2011 to 2013.
Prior to that, he worked as a Director at Biotie Therapies Oy and as a Director at Signature Capital LLC.
He also served as Managing Director at Corden Pharma GmbH.
Dr. Rautsola's earlier career includes positions as Principal at Fresenius SE & Co. KGaA, Principal at Boehringer Ingelheim GmbH, and Principal at Beiersdorf AG.
He obtained a doctorate degree from Ludwig-Maximilians-Universität München.
Ehemalige bekannte Positionen von Riku Heikki Rautsola
| Unternehmen | Position | Ende |
|---|---|---|
Corden Pharma SpA
 Corden Pharma SpA Pharmaceuticals: MajorHealth Technology Corden Pharma SpA manufactures sterile liquid dosage forms for injectable use. It offers sterile emulsion technology, pre-filled syringes, distribution of clinical trial medication, and formulation development. The company is headquartered in Caponago, Italy. | Vorstandsvorsitzender | 01.08.2019 |
Laurantis Pharma Oy
 Laurantis Pharma Oy Pharmaceuticals: MajorHealth Technology Laurantis Pharma Oy engages in the development of pharmaceutical products. The company was founded in July 2008 and is headquartered in Turku, Finland. | Vorstandsvorsitzender | 01.01.2013 |
| BIOTIE THERAPIES CORP | Direktor/Vorstandsmitglied | - |
Corden Pharma GmbH
 Corden Pharma GmbH Pharmaceuticals: MajorHealth Technology Corden Pharma GmbH engages in the development, production, testing, storage, packaging, and distribution of pharmaceutical products. The company was founded on April 14, 2010 and is headquartered in Plankstadt, Germany. | Vorstandsvorsitzender | - |
Signature Capital LLC
 Signature Capital LLC Investment ManagersFinance Founded in 1997, Signature Capital LLC is a venture capital firm located in Naples, Florida with an additional office in Portland, Maine | Direktor/Vorstandsmitglied | - |
Ausbildung von Riku Heikki Rautsola
| Ludwig-Maximilians-Universität München | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| FRESENIUS SE & CO. KGAA | Health Technology |
| BEIERSDORF | Consumer Non-Durables |
| Private Unternehmen | 9 |
|---|---|
Boehringer Ingelheim GmbH
 Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Health Technology |
VIRxSYS Corp.
 VIRxSYS Corp. BiotechnologyHealth Technology VIRxSYS Corp. is a holding company, which uses its proprietary platform technologies to develop therapies for serious human diseases. Its platform technologies include lentiviral vectors as a delivery vehicle for genes against certain diseases and for vaccine therapies. Its therapies are in various stages of development from pre-clinical through Phase II clinical trials. The company was founded by Boro Dropulic, William J. Turner, and Wiliam N. Sick Jr in 1998 and is headquartered in Gaithersburg, MD. | Health Technology |
Biotie Therapies Oy
 Biotie Therapies Oy Pharmaceuticals: MajorHealth Technology Biotie Therapies Oy engages in the research, development, and commercialization of pharmaceutical products. The company was founded by Markku Tapani Jalkanen and Sirpa Tuulikki Jalkanen in June 1992 and is headquartered in Helsinki, Finland. | Health Technology |
Borean Pharma ApS
 Borean Pharma ApS Pharmaceuticals: MajorHealth Technology Borean Pharma ApS provides biopharmaceuticals drugs and protein engineering services. Its two main components of technology platform are CTLD library technology and trimerisation technology. The company was founded by Hans Christian Thøgersen and Michael Etzerodt in 1997 and is located in Aarhus, Denmark. | Health Technology |
Cosmix molecular biologicals GmbH
 Cosmix molecular biologicals GmbH BiotechnologyHealth Technology Cosmix molecular biologicals GmbH develops peptides for therapeutics. It identifies and improves peptides for applications in healthcare, research and industry. Cosmix molecular biologicals was founded in 1997 and is headquartered in Braunschweig, Germany. | Health Technology |
Signature Capital LLC
Signature Capital LLC Investment ManagersFinance Founded in 1997, Signature Capital LLC is a venture capital firm located in Naples, Florida with an additional office in Portland, Maine | Finance |
Corden Pharma SpA
Corden Pharma SpA Pharmaceuticals: MajorHealth Technology Corden Pharma SpA manufactures sterile liquid dosage forms for injectable use. It offers sterile emulsion technology, pre-filled syringes, distribution of clinical trial medication, and formulation development. The company is headquartered in Caponago, Italy. | Health Technology |
Corden Pharma GmbH
Corden Pharma GmbH Pharmaceuticals: MajorHealth Technology Corden Pharma GmbH engages in the development, production, testing, storage, packaging, and distribution of pharmaceutical products. The company was founded on April 14, 2010 and is headquartered in Plankstadt, Germany. | Health Technology |
Laurantis Pharma Oy
Laurantis Pharma Oy Pharmaceuticals: MajorHealth Technology Laurantis Pharma Oy engages in the development of pharmaceutical products. The company was founded in July 2008 and is headquartered in Turku, Finland. | Health Technology |
